WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2026

Mar 3, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2026-03-01

Reporting Person: Green Eric Mark (Director, President, CEO and Board Chair)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-03-01	Rst. Stock Unit	$	A	6986	Acquired		Common Stock (6986)	Direct
2026-03-01	Stock Option (Right to Buy)	$254.34	A	16630	Acquired	2036-03-01	Common Stock (16630)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of WST common stock.

F2: The restricted stock units vest in four equal annual installments beginning on March 1, 2027.

F3: The stock option vests in four equal annual installments beginning on March 1, 2027.